Key result
Obesity linked to ~51% higher post-ACS LDL target attainment on statins vs lower BMI.
Why the study?
Does obesity impact LDL-c target attainment 6 weeks after statin initiation in patients with acute coronary syndrome?
Observational (n=286)
No
Does obesity impact LDL-c target attainment 6 weeks after statin initiation in patients with acute coronary syndrome?
Answers are grounded in this paper and cite their sources.
Obese patients admitted for ACS are more likely to achieve LDL-c targets at 6 weeks post-statin initiation compared to non-obese patients, highlighting a need for reinforced lipid management in the general ACS population.
Introduction Cardiovascular disease is the leading cause of death. One of the main factors is obesity, which is on the rise. LDL levels below 0.55 g/L are recommended after ACS. To date, there are no specific recommendations for obese subjects. Objective The primary objective was to assess the impact of obesity on LDL-c target attainment 6 weeks after initiation of statin therapy in subjects admitted for ACS. The secondary objectives were to assess the evolution of cholesterol levels and to characterize lipid-lowering treatments. Methods The single-center observational study took place at Montpellier University Hospital and included patients admitted to the ICU for ACS not treated with statins (T0). Biological tests were performed at 6 weeks. At 3 months, a telephone call was made by two pharmacists to collect the results of their biological work-up and any therapeutic modifications. Results The results were analyzed on 286 patients. A total of 39.5% were overweight and 22.7% obese. After hospitalization, 95.4% were prescribed statins. At 6 weeks, LDL cholesterol averaged 1.58 mmol/L, lower in subjects with a BMI greater than 30 kg/m 2 (1.32 mmol/L). On average, 49.46% of subjects reached the LDL cholesterol target, with obese subjects achieving a higher rate of 64.9%. There was no significant difference in the prescription of lipid-lowering treatments between the two groups. Conclusion Despite high-intensity statin prescription, the target was achieved by 67.6% of obese subjects and 44.8% of subjects with a BMI of less than 30 kg/m 2 . This shows that post-SCA management needs to be reinforced for the general population.
No takes yet. Share an insight, caveat, or question.
Bourgeois et al. (2024) conducted an observational in Acute coronary syndrome (n=286). Obesity (BMI > 30 kg/m2) vs. BMI < 30 kg/m2 was evaluated on LDL-c target attainment 6 weeks after initiation of statin therapy. Obese patients achieved a higher rate of LDL cholesterol target attainment 6 weeks after an acute coronary syndrome compared to patients with a BMI <30 kg/m2.
Synapse has enriched 10 related papers. Consider them for comparative context: